<https://rdf.molmedb.upol.cz/reference/ref3601> <http://purl.org/dc/terms/subject> <https://identifiers.org/molmedb/MM491183>;
	<http://purl.org/ontology/bibo/pmid> "28526367"^^<http://www.w3.org/2001/XMLSchema#string>;
	<http://purl.org/dc/terms/subject> <https://rdf.molmedb.upol.cz/interaction/method33>,
		<https://identifiers.org/molmedb/MM491205>;
	<http://purl.org/ontology/bibo/doi> "10.1016/j.bmcl.2017.05.028"^^<http://www.w3.org/2001/XMLSchema#string>;
	<http://purl.org/dc/terms/bibliographicCitation> "Barlaam B, Cosulich S, Fitzek M, Germain H, Green S, Hanson LL, Harris CS, Hancox U, Hudson K, Lambert-van der Brempt C, Lamorlette M, Magnien F, Ouvry G, Page K, Ruston L, Ward L, Delouvrié B.: Discovery of a novel aminopyrazine series as selective PI3Kα inhibitors. Bioorg Med Chem Lett, Volume 27 (13), 2017"^^<http://www.w3.org/2001/XMLSchema#string>;
	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/dc/terms/BibliographicResource>;
	<http://purl.org/dc/terms/subject> <https://rdf.molmedb.upol.cz/interaction/membrane21> .
<https://rdf.molmedb.upol.cz/interaction/int1025221> <http://www.w3.org/ns/prov#hadPrimarySource> <https://rdf.molmedb.upol.cz/reference/ref3601> .
<https://rdf.molmedb.upol.cz/interaction/int1025257> <http://www.w3.org/ns/prov#hadPrimarySource> <https://rdf.molmedb.upol.cz/reference/ref3601> .
